Q2 EPS Estimate for Foghorn Therapeutics Cut by Analyst
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – B. Riley lowered their Q2 2025 earnings estimates for Foghorn Therapeutics in a report issued on Wednesday, May 14th. B. Riley analyst K. Patel now forecasts that the company will post earnings of ($0.36) per share for the quarter, down from their previous estimate of ($0.32). B. […]
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – B. Riley lowered their Q2 2025 earnings estimates for Foghorn Therapeutics in a report issued on Wednesday, May 14th. B. Riley analyst K. Patel now forecasts that the company will post earnings of ($0.36) per share for the quarter, down from their previous estimate of ($0.32). B. […]
